A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search

2016 Medicare Part D Formulary Search By Drug Letter

This is archive material for research purposes. Please see PDPFinder.com or MAFinder.com for current plans.
Select a Letter below:
Links to Summaries by State for LTC Drugs on LIS/SNP Plans:
AK  AL  AR  AZ  CA  CO  CT  DC  DE  FL  GA  HI  IA  ID  IL  IN  KS  KY  LA  MA  MD  ME  MI  MN  MO  MS  MT  NC  ND  NE  NH  NJ  NM  NV  NY  OH  OK  OR  PA  PR  RI  SC  SD  TN  TX  UT  VA  VT  WA  WI  WV  WY

Drug Names Containing the Letter X in Alphabetical Order.
Example: Lipitor® is found on letter page "L" as well as letter page "A" for Atorvastatin.

Drug Name
PackagingNDCOn This Nbr of 2016 Formularies
PDPsMAPDs
TETRABENAZINE 12.5 MG TABLET [XENAZINE]
(Tetrabenazine)
   6868204211261
PDPs
326
MAPDs
TETRABENAZINE 25 MG TABLET [XENAZINE]
(Tetrabenazine)
   6868204222561
PDPs
326
MAPDs
XALATAN EYE DROPS 125MCG 2.5ML BOTPL
(Latanoprost Ophth)
2.5 ML BOTPL000138303043
PDPs
16
MAPDs
Xalkori 200mg/1 60 CAPSULE BOTTLE
(CRIZOTINIB)
60 CAPSULE in 1 BOTTLE  0006981412062
PDPs
338
MAPDs
Xalkori 250mg/1 60 CAPSULE BOTTLE
(CRIZOTINIB)
60 CAPSULE in 1 BOTTLE  0006981402062
PDPs
338
MAPDs
Xanax 0.25mg/1 500 TABLET BOTTLE
(Alprazolam)
500 TABLET in 1 BOTTLE  000090029021
PDPs
13
MAPDs
Xanax 0.5mg/1 100 TABLET BOTTLE
(Alprazolam)
100 TABLET in 1 BOTTLE  000090055011
PDPs
13
MAPDs
Xanax 1mg/1 100 TABLET BOTTLE
(Alprazolam)
100 TABLET in 1 BOTTLE  000090090011
PDPs
13
MAPDs
Xanax 2mg/1 100 TABLET BOTTLE
(Alprazolam)
100 TABLET in 1 BOTTLE  000090094011
PDPs
13
MAPDs
Xanax XR 0.5mg/1 60 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Alprazolam)
60 TABLET, EXTENDED RELEA  000090057071
PDPs
12
MAPDs
Xanax XR 1mg/1 60 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Alprazolam)
60 TABLET, EXTENDED RELEA  000090059071
PDPs
12
MAPDs
Xanax XR 2mg/1 60 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Alprazolam)
60 TABLET, EXTENDED RELEA  000090066071
PDPs
12
MAPDs
Xanax XR 3mg/1 60 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Alprazolam)
60 TABLET, EXTENDED RELEA  000090068071
PDPs
12
MAPDs
XARELTO STARTER PACK
(Rivaroxaban)
51 EA  5045805845160
PDPs
322
MAPDs
XARELTO 10 MG 10 BLISTER PACK per CARTON / 10 TABLET per BLISTER PACK
(rivaroxaban)
10 BLISTER PACK in 1 CART  5045805801062
PDPs
337
MAPDs
XARELTO 15 MG TABLET
(rivaroxaban)
100 EA  5045805781061
PDPs
336
MAPDs
XARELTO 20 MG TABLET
(rivaroxaban)
100 EA  5045805791061
PDPs
336
MAPDs
XARTEMIS XR 7.5-325 MG TABLET
(oxycodone / acetaminophen)
   236350115016
PDPs
37
MAPDs
XELJANZ XR 11 MG TABLET
(Tofacitinib Citrate)
   0006905013013
PDPs
149
MAPDs
XELJANZ 5 MG TABLET
(tofacitinib citrate)
60 EA  0006910010115
PDPs
169
MAPDs
XENAZINE TABLETS 12.5MG 112 BOT
(Tetrabenazine)
112 BOT6738604210143
PDPs
214
MAPDs
XENAZINE TABLET 25 MG
(Tetrabenazine)
112 BOT6738604220143
PDPs
215
MAPDs
Xeomin 50[USP'U]/1 1 VIAL, SINGLE-USE per CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
(BOTULINUM TOXIN TYPE A)
1 VIAL, SINGLE-USE in 1 C  002591605014
PDPs
52
MAPDs
XERESE 5%-1% CREAM
(acyclovir and hydrocortisone topical)
5 GM  001875104015
PDPs
39
MAPDs
XGEVA 120mg/1.7mL 1 VIAL, SINGLE-USE per CARTON / 1.7 mL in 1 VIAL, SINGLE-USE
(DENOSUMAB)
1 VIAL, SINGLE-USE in 1 C  5551307300160
PDPs
317
MAPDs
XIFAXAN 200MG TABLET
(Rifaximin)
30 BOT6564903010330
PDPs
197
MAPDs
XIFAXAN 550MG TABLETS
(Rifaximin)
10 X 6 BLPK CRTN 6564903030353
PDPs
283
MAPDs
XIGDUO XR 10 MG-1,000 MG TAB
(Dapagliflozin and Metformin Hydrochloride)
30 EA  0031062803021
PDPs
116
MAPDs
XIGDUO XR 10 MG-500 MG TABLET
(Dapagliflozin and Metformin Hydrochloride)
30 EA  0031062703021
PDPs
116
MAPDs
XIGDUO XR 5 MG-500 MG TABLET
(Dapagliflozin and Metformin Hydrochloride)
30 EA  0031062503021
PDPs
116
MAPDs
XIGDUO XR 5 MG-1,000 MG TABLET
(Dapagliflozin and Metformin Hydrochloride)
60 EA  0031062606021
PDPs
116
MAPDs
XODOL 10-300MG TABLET
(Hydrocodone-Acetaminophen)
   596300911102
PDPs
24
MAPDs
XODOL 5-300 TABLET
(Hydrocodone-Acetaminophen)
   596300912102
PDPs
25
MAPDs
XODOL 7.5-300 MG TABLET
(Hydrocodone-Acetaminophen)
   596300913102
PDPs
24
MAPDs
XOLAIR 150MG VIAL
(Omalizumab For)
1 X VIAL5024200406262
PDPs
334
MAPDs
XOPENEX 0.31 MG/3 ML SOLUTION
(Levalbuterol HCl)
3 ML  174780172242
PDPs
16
MAPDs
XOPENEX 0.63 MG/3 ML SOLUTION
(Levalbuterol HCl)
   174780173242
PDPs
16
MAPDs
XOPENEX 1.25 MG/3 ML SOLUTION
(Levalbuterol HCl)
   174780174242
PDPs
21
MAPDs
XOPENEX HFA 45MCG HFA AEROSOL WITH ADAPTER
(Levalbuterol Tartrate)
200 INHALATIONS BOX6340205100134
PDPs
162
MAPDs
XTAMPZA ER 13.5 MG CAPSULE
(Oxycodone)
   245100115102
PDPs
8
MAPDs
XTAMPZA ER 18 MG CAPSULE
(Oxycodone)
   245100120102
PDPs
8
MAPDs
XTAMPZA ER 27 MG CAPSULE
(Oxycodone)
   245100130102
PDPs
8
MAPDs
XTAMPZA ER 36 MG CAPSULE
(Oxycodone)
   245100140102
PDPs
8
MAPDs
XTAMPZA ER 9 MG CAPSULE
(Oxycodone)
   245100110102
PDPs
8
MAPDs
XTANDI 40 MG CAPSULE
(enzalutamide)
   0046901259962
PDPs
338
MAPDs
Xulane Patch
(norelgestromin / ethinyl estradiol)
   0037833405335
PDPs
233
MAPDs
XYLOCAINE 2% VIAL
(Lidocaine HCl)
   633230486271
PDPs
14
MAPDs
XYREM 500MG/ML ORAL SOLUTION
(Sodium Oxybate Oral)
180 ML BOT6872701000162
PDPs
338
MAPDs
XYZAL 2.5 MG/5 ML SOLUTION
(Levocetirizine Dihydrochloride)
148 ML  504740921051
PDPs
11
MAPDs
XYZAL 5 MG TABLET
(Levocetirizine Dihydrochloride)
90 EA  504740920903
PDPs
13
MAPDs



(Chart Source: Centers for Medicare and Medicaid files: CMS Data )





Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.